Fujii N, Omori S, Kataoka Y, Maimaituxun G, Bailey SJ, Lloyd AB, Arnold JT, Amano T, Tanabe Y, Omi N, Watanabe K, Nishiyasu T
PubMed PMID: 23449527
However, long-term administration of GCs at high doses is frequently associated with severe adverse effects, in particular, metabolic disorders and atrophic effects, including musculoskeletal side effects (glucocorticoid-induced osteoporosis (GIO), osteonecrosis, myopathy), disorders of carbohydrate and fat metabolism (diabetes mellitus, dyslipidemia, obesity), gastrointestinal, cardiovascular effects (Fig
Co-encapsulating the fusogenic peptide INF7 and molecular imaging probes in liposomes increases intracellular signal and probe retention
Mol Cell Biol 26:47014711
Further inquiries can be directed to the corresponding author/s